ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

GSK Gsk Plc

1,705.00
-0.20 (-0.01%)
Last Updated: 08:32:09
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Gsk Plc LSE:GSK London Ordinary Share GB00BN7SWP63 ORD 31 1/4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.20 -0.01% 1,705.00 1,704.80 1,705.60 1,708.60 1,699.40 1,701.60 172,410 08:32:09
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 30.33B 4.93B 1.1970 14.24 70.15B

GlaxoSmithKline Posts GBP354 Million Net Loss in 4Q

03/02/2016 1:23pm

Dow Jones News


Gsk (LSE:GSK)
Historical Stock Chart


From Mar 2019 to Mar 2024

Click Here for more Gsk Charts.
By Denise Roland 

GlaxoSmithKline PLC swung to a net loss in the fourth quarter of the year even as revenue increased, largely due to restructuring costs following its three-part transaction with Novartis AG.

The U.K.-based drugmaker said its loss attributable to shareholders was GBP354 million ($510 million) in the quarter ending Dec. 31, compared with a GBP1 billion profit a year earlier, while revenue climbed to GBP6.3 billion from GBP6.2 billion. Core net profit, which strips out some one-time items, fell 34% to GBP874 million. Analysts had expected revenue of GBP6.3 billion and core net profit of GBP903 million.

The decline in core net profit was largely down to Glaxo's shift to a higher-volume, lower-margin business following its $20 billion asset-swap deal with Novartis. In that deal, which closed in the first quarter of 2015, Glaxo traded its cancer drugs for the Swiss company's vaccines business. The pair also formed a joint venture for their consumer health care businesses which span over-the-counter drugs, such as painkiller Panadol, as well as non-pharmaceuticals like toothpaste.

Write to Denise Roland at Denise.Roland@wsj.com

 

(END) Dow Jones Newswires

February 03, 2016 08:08 ET (13:08 GMT)

Copyright (c) 2016 Dow Jones & Company, Inc.

1 Year Gsk Chart

1 Year Gsk Chart

1 Month Gsk Chart

1 Month Gsk Chart

Your Recent History

Delayed Upgrade Clock